Consistent with this hypothesis, their data indicate that CARMA3 and Bcl10 are required for EGFR-induced NF-κB activation in both EGFR-expressing human cancer cell lines and mouse embryonic fibroblasts (41). This evidence concerns the gene NFKB1 and cancer.